APR 25, 2019 7:30 AM PDT

Keynote Presentation: Ebola Virus Disease - 2019 and Beyond

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
    Biography
      Dr. Colleen Kraft is an infectious diseases-trained physician and a clinical microbiologist. She is a member of the leadership group for the Serious Communicable Diseases Unit at Emory University Hospital in Atlanta, GA. She was one of the physicians in the care of patients with Ebola virus disease and Lassa Fever at Emory University Hospital from 2014-2016. Dr. Kraft is a co-PI for the National Ebola Training and Education Center, a federally funded collaborative between Emory, Nebraska Medicine, and New York Health and Hospital-Bellevue. She is also the PI on the NIOSH PPTL contract to evaluate elastomeric respirators in the healthcare center. Her vision for the Serious Communicable Diseases Unit is to use the subject matter expertise that was gained from the care of these patients with special pathogens and bring those lessons into everyday healthcare.

    Abstract

    The Ebola virus disease outbreak in West Africa in 2014-2016 was the largest of its kind in history.  This was the first outbreak that involved a randomized clinical trial for therapeutics, and the first where affected individuals were repatriated to other countries. Knowledge regarding Ebola virus disease dramatically increased during this outbreak, and more was learned clinically, epidemiologically and scientifically.  This lecture describes the advances from this outbreak in the context of the current outbreak that is occurring in the Democratic Republic of the Congo.  

    Learning Objectives: 

    1. Know the current status of the Ebola outbreak in the Democratic Republic of the Congo
    2. Understand the current state of therapeutics for Ebola virus disease


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more